Regulation of innate immunity and tumour progression by activating transcription factor 3

Williams, Bryan (Primary Chief Investigator (PCI))
Xu, Dakang (Chief Investigator (CI))

Project: Research

Status	Finished
Effective start/end date	1/01/11 → 31/12/13

Funding

National Health & Medical Research Council (NHMRC): AUD457,128.00

Related content

Research Output

Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling

Research output: Contribution to journal › Article › Research › peer-review

Activating transcription factor 3 contributes to Toll-like receptor-mediated macrophage survival via repression of Bax and Bak

Research output: Contribution to journal › Article › Research › peer-review